Malawi TB Cases Drop 40% as New Technology Boosts Detection
The World Health Organisation reported 25,000 new TB cases in Malawi during 2023, representing an incidence rate of 119 per 100,000 people.
LILONGWE, Malawi— Malawi has reduced its tuberculosis rate by 40% through an ambitious program combining artificial intelligence, rapid testing, and community outreach, despite persistent challenges in the southeastern African nation, writes Meclina Chirwa.
The World Health Organisation reported 25,000 new TB cases in Malawi during 2023, representing an incidence rate of 119 per 100,000 people.
Health officials project the rate will drop by half before 2025.
"We're working tirelessly to identify and treat TB cases, especially in high-risk communities," said Madalitso M'manga, who coordinates Active TB Case Finding at the National TB and Leprosy Elimination Program (NTLEP).
The program achieved a 4.4% increase in case notification and now provides treatment to three-quarters of TB patients.
NTLEP has modernised its diagnostic capabilities by deploying Genexpert machines, which deliver results within two hours, alongside AI-powered digital X-ray screening for suspected TB cases.
"The introduction of new diagnostic tools has revolutionised TB diagnosis in Malawi," said Dr. Kuzani Mbendera, NTLEP Programs Manager.
"With accurate and rapid diagnosis, we can provide timely treatment and improve patient outcomes."
The program faces ongoing obstacles, including funding shortages, high HIV rates that complicate treatment, and difficulty identifying TB cases in children.
Officials are countering these challenges by expanding community-based initiatives and equipping health workers with new technology.
"We're committed to ending TB in Malawi and making progress," M'manga said.
"But we need continued support and funding to overcome the remaining challenges and achieve our goals."
The NTLEP plans to strengthen its community outreach efforts and seek additional resources to sustain its technological improvements in TB detection and treatment.